Subclinical atrial fibrillation and the risk of stroke

New England Journal of Medicine

Volumn 366, Issue 14, 2012, Pages 1352-

  Bersohn, Malcolm M ^a   Waldo, Albert L ^b   Halperin, Jonathan L ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ARTIFICIAL HEART PACEMAKER; BLEEDING; BRAIN ISCHEMIA; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; DEFIBRILLATOR; DISEASE ASSOCIATION; EMBOLISM; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART RHYTHM; HUMAN; LETTER; OUTCOME ASSESSMENT; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; EMBOLISM; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; STROKE;

EID: 84859407840     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010;122:325-32.
2. Ip J, Waldo AL, Lip GY, et al. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with ICD and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort: the IMPACT Study. Am Heart J 2009;158(3):364.e1-370.e1.